2m 2m 2m 2m 2m 2m 2m
Cardiff (CDIX)
OTC
$0.59+$0.08 (+15.21%)
Price as of Jul 31, 2026- $9.0MMarket Cap
- -85.60%1-Year Change
- Medical Care FacilitiesIndustry
Cardiff (CDIX)
$0.59+$0.08 (+15.21%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 11.5M +39.48% | 8.3M -30.23% | 11.9M -1.21% | 12.0M +19.88% | |
Cost of Revenue | 4.3M +12.70% | 3.8M +7.89% | 3.6M -20.12% | 4.5M +15.82% | |
Gross Profit | 7.2M +62.72% | 4.4M -46.60% | 8.3M +9.97% | 7.5M +22.41% | |
Sales and Marketing Expense | 5.3M +31.23% | 4.1M +32.08% | 3.1M -17.59% | 3.7M -17.40% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 5,652 -58.01% | 13,461 -35.21% | 20,777 -10.18% | 23,131 -34.54% | |
Total Operating Expenses | 6.1M +32.10% | 4.6M +49.21% | 3.1M -47.04% | 5.8M +28.99% | |
Operating Profit | 1.1M +668.77% | -193,504 -103.72% | 5.2M +207.04% | 1.7M +4.05% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -111,588 -96.34% | -3.0M +55.68% | -2.0M -69.40% | -6.4M +114.30% | |
Interest Income and Expense and Net | -111,588 -96.34% | -3.0M +55.68% | -2.0M -69.40% | -6.4M +114.30% | |
Total Nonoperating Income and Expense | -6.8M +128.35% | -3.0M +44.13% | -2.1M -70.96% | -7.2M +134.45% | |
Income before Taxes | -5.7M +80.03% | -3.2M -202.46% | 3.1M +156.94% | -5.5M +282.84% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | 0 -100.00% | 1.4M N/A | |
Net Income | -6.5M +53.38% | -4.3M -240.84% | 3.0M +155.78% | -5.4M +1,225.22% | |
Net Income from Continuing Operations Applicable to Common | -6.5M +53.38% | -4.3M -289.70% | 2.2M +141.10% | -5.5M +1,235.22% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | 167.00 +1,670,100.00% | -0.01 -99.69% | |
Diluted EPS and Net Income | N/A N/A | N/A N/A | 2.00 +20,100.00% | -0.01 -99.69% | |
Basic Weighted Average Shares | 6.9M -39.45% | 11.4M +79,120.65% | 14,444 -100.00% | 436.6M +241.07% | |
Diluted Weighted Average Shares | 8.5M -25.72% | 11.4M +76,179.12% | 15,001 -100.00% | 436.6M +241.07% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 318,535 -73.19% | 1.2M +37.05% | 866,943 +282.25% | 226,802 -61.95% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 318,535 -73.19% | 1.2M +37.05% | 866,943 +282.25% | 226,802 -61.95% | |
Total Current Assets | 22.6M +31.26% | 17.2M +21.41% | 14.2M +107.37% | 6.8M +23.19% | |
Accumulated Depreciation | 60,905 -47.29% | 115,552 +13.19% | 102,089 -0.11% | 102,206 -53.22% | |
Property and Plant and Equipment and Net | 2,953 -86.07% | 21,198 -38.84% | 34,661 -37.48% | 55,439 -78.60% | |
Total Long-Term Assets | 64,182 -12.52% | 73,368 +120.30% | 33,304 +8.05% | 30,823 -20.73% | |
Total Assets | 29.1M +21.57% | 23.9M +15.33% | 20.7M +55.36% | 13.4M +19.65% | |
Income Taxes Payable | 5,323 +60.48% | 3,317 -37.95% | 5,346 -20.59% | 6,732 -10.87% | |
Total Short-Term Debt | 17.5M +92.58% | 9.1M +52.50% | 5.9M +68.29% | 3.5M +39.26% | |
Total Current Liabilities | 25.8M +62.60% | 15.9M +14.62% | 13.9M +38.97% | 10.0M +22.92% | |
Total Long-Term Debt | 138,773 -44.87% | 251,725 +74.00% | 144,666 +3.49% | 139,789 -2.08% | |
Total Long-Term Liabilities | 42,976 -76.88% | 185,877 +56.13% | 119,056 +40.28% | 84,871 -30.58% | |
Total Liabilities | 26.0M +59.36% | 16.3M +15.58% | 14.1M +38.50% | 10.2M +21.72% | |
Retained Earnings | -79.5M +8.97% | -72.9M +6.21% | -68.7M -3.06% | -70.9M +7.04% | |
Total Stockholders Equity | 27.3M +918.54% | 2.7M +267.12% | 731,418 +149.76% | -1.5M -152.84% | |
Total Shares Outstanding | 13.7M -10.45% | 15.3M +63,479.78% | 24,065 -100.00% | 789.8M +375.41% | |
Cash Flow | |||||
Cash from Operating Activities | -2.9M +7.49% | -2.7M +54.20% | -1.7M +50.61% | -1.1M +10.29% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash from Investing Activities | N/A N/A | N/A N/A | N/A N/A | 0 +100.00% | |
Dividends Paid | 50,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.0M -33.34% | 3.0M +25.59% | 2.4M +200.37% | 788,794 -78.55% | |
Financials Ratio | |||||
Gross Margin | 62.47% +16.66% | 53.55% -23.46% | 69.96% +11.31% | 62.85% +2.11% | |
Operating Margin | 9.54% +507.76% | -2.34% -105.34% | 43.83% +210.79% | 14.10% -13.20% | |
Return on Assets | -24.68% +29.25% | -19.10% -207.51% | 17.76% +140.10% | -44.30% +769.85% | |
Return on Equity | -43.56% -82.55% | -249.67% -69.56% | -820.27% -0.93% | -827.95% -6,254.44% | |
Revenue Growth | 39.48% +230.62% | -30.23% +2,401.17% | -1.21% -106.08% | 19.88% -89.53% | |
Current Ratio | 0.87 -19.28% | 1.08 +5.93% | 1.02 +49.20% | 0.69 +0.22% | |
Cash Ratio | 0.01 -83.56% | 0.07 +19.68% | 0.06 +175.33% | 0.02 -69.12% | |
Debt-to-Equity Ratio | 0.64 -81.46% | 3.47 -58.32% | 8.32 +433.22% | -2.50 -359.35% | |
Debt-to-Assets Ratio | 0.60 +55.36% | 0.39 +32.69% | 0.29 +6.73% | 0.27 +14.54% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow